CVS Caremark to buy Apria's infusion business for $2.1 billion-Reuters

CVS Caremark Corp said on Wednesday it was buying Coram LLC, Apria Healthcare Group Inc's specialty infusion services and enteral nutrition business unit, for $2.1 billion, Reuters reported.

27 November 2013•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles